• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全血凝块溶解:活化蛋白C的体外调节作用

Whole blood clot lysis: in vitro modulation by activated protein C.

作者信息

Taylor F B, Lockhart M S

出版信息

Thromb Res. 1985 Mar 15;37(6):639-49. doi: 10.1016/0049-3848(85)90193-8.

DOI:10.1016/0049-3848(85)90193-8
PMID:3838829
Abstract

Lysis of clots prepared from native or citrated whole blood as measured by release of 125I fibrinogen degradation products was 10% or less at 20 hours. Lysis of these clots was accelerated by activated protein C in a dose-dependent manner (0.1 to 20 micrograms/ml) from less than 10% to 60-80% at 20 hours. Lysis of clots prepared from native or citrated platelet poor plasma across the same concentration range of activated protein C was less than 15%. Gla-domain-less activated protein C was equally effective in accelerating clot lysis whereas DIP-activated protein C or factor Xa did not accelerate clot lysis. This suggested that this action of activated protein C was enzymatic and this this action was limited to protein C among the vitamin K dependent proteins. The unresponsiveness of platelet poor plasma to activated protein C was completely restored to that of whole blood by addition of mononuclear leukocytes. Addition of red corpuscles or platelets alone had no effect on this response, while addition of polymorphonuclear leukocytes partially restored this response. Addition of metabolic inhibitors 2-deoxyglucose and oligomycin inhibited the response of whole blood and of plasma-mononuclear leukocytes to activated protein C. Reconstitution studies of platelet poor plasma made deficient in plasminogen activator and plasminogen showed that accelerated clot lysis produced by mononuclear leukocytes and activated protein C required the presence of plasminogen. We concluded, therefore, that activated protein C accelerates whole blood or plasma-leukocyte clot lysis by modulating activation of the plasminogen system by metabolically active leukocytes.

摘要

通过释放125I纤维蛋白原降解产物来测定,由天然或枸橼酸化全血制备的凝块在20小时时的溶解率为10%或更低。这些凝块的溶解在20小时时被活化蛋白C以剂量依赖方式(0.1至20微克/毫升)加速,从低于10%加速至60 - 80%。在相同浓度范围的活化蛋白C作用下,由天然或枸橼酸化少血小板血浆制备的凝块溶解率小于15%。无γ-羧基谷氨酸结构域的活化蛋白C在加速凝块溶解方面同样有效,而二异丙基磷酰基活化蛋白C或因子Xa则不能加速凝块溶解。这表明活化蛋白C的这一作用是酶促作用,且在维生素K依赖性蛋白中,这一作用仅限于蛋白C。通过添加单核白细胞,少血小板血浆对活化蛋白C的无反应性完全恢复至全血的反应性。单独添加红细胞或血小板对此反应无影响,而添加多形核白细胞可部分恢复此反应。添加代谢抑制剂2 - 脱氧葡萄糖和寡霉素可抑制全血以及血浆 - 单核白细胞对活化蛋白C的反应。对缺乏纤溶酶原激活物和纤溶酶原的少血小板血浆进行的重组研究表明,单核白细胞和活化蛋白C产生的加速凝块溶解需要纤溶酶原的存在。因此,我们得出结论,活化蛋白C通过调节代谢活跃的白细胞对纤溶酶原系统的激活来加速全血或血浆 - 白细胞凝块溶解。

相似文献

1
Whole blood clot lysis: in vitro modulation by activated protein C.全血凝块溶解:活化蛋白C的体外调节作用
Thromb Res. 1985 Mar 15;37(6):639-49. doi: 10.1016/0049-3848(85)90193-8.
2
Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.对稀释全血凝块回缩和溶解以及血小板聚集和回缩过程中涉及的因素进行定性描述。
J Clin Invest. 1970 Nov;49(11):2068-85. doi: 10.1172/JCI106425.
3
The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro.蛋白S在体外对活化蛋白C加速全血凝块溶解中的辅助因子作用。
Blood. 1986 Apr;67(4):1189-92.
4
Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.纤溶酶原、纤溶酶原激活物及血小板在凝块溶解调节中的作用。重建及患者研究。
J Lab Clin Med. 1982 Dec;100(6):986-96.
5
A new function for activated protein C: activated protein C prevents inhibition of plasminogen activators by releasate from mononuclear leukocytes--platelet suspensions stimulated by phorbol diester.活化蛋白C的一种新功能:活化蛋白C可通过释放佛波酯刺激的单核白细胞-血小板悬液中的物质来防止纤溶酶原激活剂受到抑制。
Thromb Res. 1985 Jan 1;37(1):155-64. doi: 10.1016/0049-3848(85)90042-8.
6
"Plasminogen steal" and clot lysis.“纤溶酶原夺取”与血栓溶解
J Am Coll Cardiol. 1992 Apr;19(5):1085-90. doi: 10.1016/0735-1097(92)90300-c.
7
Protein C and fibrinolysis: a link between coagulation and fibrinolysis.蛋白C与纤维蛋白溶解:凝血与纤维蛋白溶解之间的联系。
Adv Exp Med Biol. 1990;281:235-43. doi: 10.1007/978-1-4615-3806-6_23.
8
Activated protein C accelerates clot lysis by virtue of its anticoagulant activity.活化蛋白C凭借其抗凝活性加速血栓溶解。
Blood Coagul Fibrinolysis. 1993 Apr;4(2):201-10. doi: 10.1097/00001721-199304000-00001.
9
Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.纤溶酶原激活剂和抗血小板药物联合作用下,富含血小板的纤维蛋白凝块在体外的快速溶解
J Pharmacol Exp Ther. 1991 Dec;259(3):1371-8.
10
Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.低分子量肝素对纤维蛋白聚合及凝块对组织型纤溶酶原激活物(t-PA)诱导纤溶敏感性的影响。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):721-7.

引用本文的文献

1
Comparative response of platelet fV and plasma fV to activated protein C and relevance to a model of acute traumatic coagulopathy.血小板因子V和血浆因子V对活化蛋白C的比较反应及其与急性创伤性凝血病模型的相关性。
PLoS One. 2014 Jun 12;9(6):e99181. doi: 10.1371/journal.pone.0099181. eCollection 2014.
2
Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study.活化蛋白 C 可改善凝血功能障碍,但不能影响致死性 H1N1 流感的结局:一项对照实验室研究。
Crit Care. 2010;14(2):R65. doi: 10.1186/cc8964. Epub 2010 Apr 14.
3
Enhanced spontaneous thrombolysis: a new therapeutic challenge.
增强型自发性溶栓:一项新的治疗挑战。
J Thromb Thrombolysis. 2006 Jun;21(3):221-7. doi: 10.1007/s11239-006-6579-0.
4
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.抗凝血蛋白C基因的失活会导致小鼠出现致死性围产期消耗性凝血病。
J Clin Invest. 1998 Oct 15;102(8):1481-8. doi: 10.1172/JCI3011.
5
Clinical relevance of protein C.
Blut. 1986 Aug;53(2):63-75. doi: 10.1007/BF00321089.
6
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.蛋白C可预防狒狒输注大肠杆菌后的凝血病变和致死效应。
J Clin Invest. 1987 Mar;79(3):918-25. doi: 10.1172/JCI112902.